Free Mesothelioma Information Packet

Daniel H. Sterman M.D.

  • Associate Professor of Medicine
  • University of Pennsylvania Medical Center
  • 215-614-0984

Daniel Sterman graduated with his Bachelors of Arts in European History from Brown University in 1985. He then pursued his Medical Degree at Cornell University Medical Center where he graduated in 1989. His internship and residency was in Internal Medicine at the Hospital of the University of Pennsylvania from 1989 to 1992. He then completed an instructorship in Emergency Medicine at the Hospital of the University for Pennsylvania from 1992 to 1993. From 1993 to 1997 he completed a fellowship in Pulmonary and Critical Care Medicine at the University of Pennsylvania medical Center. While completing this fellowship, Dr. Sterman received advanced training in Interventional Bronchoscopy and Pleuroscopy. During this time he also finished a Postdoctoral Research Fellowship in the Thoracic Oncology Research Laboratory of the University of Pennsylvania Medical Center. In 1997 he became a faculty member at the University of Pennsylvania as an Assistant Professor of Medicine in the Pulmonary Division. He currently holds this position and he is an Associate Professor of Medicine in Surgery and the Director of the University of Pennsylvania Interventional Pulmonology Program and Clinical Director of the Thoracic Oncology Gene Therapy Program of the Center for Lung Cancer and Related Disorders.

Dr. Sterman researches the clinical presentation, diagnosis, and staging of malignant mesothelioma. His focus for clinical trials is genetic immunotherapy for thoracic malignancies which uses intrapleural adenovirus mediated human interferon gene transfer for patients with pleural malignancies. He, along with colleagues, is developing trials that deliver interferon-alpha gene via adenoviral vector that may help in the treatment of mesothelioma if done in combination with chemotherapy and radiotherapy. Another clinical trial initiates a multicenter Phase I trial of intravenous delivery of a recombinant, attenuated Listeria monocytogense bacterial vector expressing the gene for human Mesothelin, a cell surface protein expressed in one hundred percent of mesotheliomas.

References:
  • University of Pennsylvania Medical Center. Physician Profile.

Last modified: December 24, 2010.